LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 40 filers reported holding LUMOS PHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $9,928 | -20.3% | 4,387 | 0.0% | 0.01% | -20.0% |
Q1 2024 | $12,459 | -10.7% | 4,387 | 0.0% | 0.01% | -16.7% |
Q4 2023 | $13,951 | -3.6% | 4,387 | 0.0% | 0.01% | 0.0% |
Q3 2023 | $14,477 | 0.0% | 4,387 | 0.0% | 0.01% | 0.0% |
Q2 2023 | $14,477 | -0.3% | 4,387 | 0.0% | 0.01% | 0.0% |
Q1 2023 | $14,521 | -8.3% | 4,387 | 0.0% | 0.01% | -14.3% |
Q4 2022 | $15,837 | -58.3% | 4,387 | +0.1% | 0.01% | -60.0% |
Q3 2022 | $38,000 | +15.2% | 4,382 | 0.0% | 0.04% | +25.0% |
Q2 2022 | $33,000 | -17.5% | 4,382 | 0.0% | 0.03% | -15.2% |
Q1 2022 | $40,000 | +33.3% | 4,382 | 0.0% | 0.03% | +37.5% |
Q4 2021 | $30,000 | – | 4,382 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lion Point Capital, LP | 407,192 | $14,540,000 | 2.80% |
Opaleye Management Inc. | 281,287 | $10,045,000 | 1.31% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 936,291 | $33,435,000 | 0.66% |
NEA Management Company, LLC | 526,663 | $18,807,000 | 0.50% |
Investors Financial Group, LLC | 18,200 | $650,000 | 0.43% |
One68 Global Capital, LLC | 5,855 | $209,000 | 0.42% |
Wealth Advisors of Iowa, LLC | 11,760 | $420,000 | 0.26% |
Blackstone Inc. | 468,145 | $16,717,000 | 0.06% |
Foster Group, Inc. | 7,283 | $221,000 | 0.04% |
Texas Yale Capital Corp. | 16,000 | $571,000 | 0.04% |